JP Morgan Chase
DMK

JP Morgan Chase’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

JP Morgan Chase’s Portfolio DMK Stock Details DMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-106,209
Closed -$74.4K – 8082
2023
Q4 		$74.4K Buy
106,209
+71,503
+206% +$41.5K ﹤0.01% 5859
2023
Q3 		$23.9K Buy
34,706
+33,022
+1,961% +$42.2K ﹤0.01% 6025
2023
Q2 		$4.03K Buy
1,684
+1,678
+27,967% +$7.17K ﹤0.01% 6212
2023
Q1 		$0 Hold
6
– – ﹤0.01% 7378
2022
Q4 		$0 Sell
6
-2
-25% -$23 ﹤0.01% 7154
2022
Q3 		$0 Sell
8
-403
-98% -$10.4K ﹤0.01% 6989
2022
Q2 		$14K Sell
411
-800
-66% -$25K ﹤0.01% 5978
2022
Q1 		$48K Sell
1,211
-1,911
-61% -$82K ﹤0.01% 5817
2021
Q4 		$132K Buy
3,122
+2,748
+735% +$171K ﹤0.01% 5563
2021
Q3 		$25K Sell
374
-239
-39% -$17.5K ﹤0.01% 6004
2021
Q2 		$47K Buy
613
+444
+263% +$27K ﹤0.01% 5754
2021
Q1 		$11K Buy
+169
New +$13.2K ﹤0.01% 5789
2020
Q4 		– Sell
-239
Closed -$10.6K – 6024
2020
Q3 		$13K Buy
+239
New +$14.2K ﹤0.01% 5229

Other funds holding DMK

CPA
Clear Point Advisors Melville, New York $129M AUM 12.02% 1-Year Est. Return
OPTFSNA
Old Point Trust & Financial Services N A Newport News, Virginia $311M AUM 24.14% 1-Year Est. Return

JP Morgan Chase's DMK Position: Q1 2024 in Review

JP Morgan Chase sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q1 2024, closing a stake of 106,209 shares — an estimated $74.4K sold.

JP Morgan Chase first reported a position in DMK in Q3 2020 and held it in 13 quarters. The position peaked at $132K in Q4 2021. 3 funds tracked by Wall St. Rank hold DMK as of Q1 2024.

  • JP Morgan Chase reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q1 2024 after selling out during the quarter.
  • JP Morgan Chase sold 106,209 DMK Pharmaceuticals Corporation Common Stock shares in Q1 2024, an estimated $74.4K.
  • JP Morgan Chase first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q3 2020 and held it in 13 quarters.
  • JP Morgan Chase's DMK Pharmaceuticals Corporation Common Stock position peaked at $132K in Q4 2021.
  • 3 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q1 2024.

Based on JP Morgan Chase's 13F filing for Q1 2024, filed 10 May 2024.